PEGLOTICASE
Substance profile for UNII R581OT55EA, enriched with FDA NDC listings, DailyMed labels, legacy aliases, and open chemistry identifiers.
Substance Identity#
- UNII
- R581OT55EA
- Preferred term
- PEGLOTICASE
- Registry number
- 885051-90-1
- Ingredient type
- INGREDIENT SUBSTANCE
Chemical And Database Identifiers#
- RxCUI
- 1011650
- PubChem
- 0
- NCIt
- C97466
- INN ID
- 8934
Open Chemistry Sources#
| Source | Identifier | Link |
|---|---|---|
| RxNorm | 1011650 | https://mor.nlm.nih.gov/RxNav/search?searchBy=RXCUI&searchTerm=1011650 |
| NCI Thesaurus | C97466 | https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C97466 |
| FDA Substance Registration System | R581OT55EA | https://precision.fda.gov/uniisearch/srs/unii/R581OT55EA |
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|---|---|---|---|---|
| PEGLOTICASE | ACTIVE MOIETY | R581OT55EA | These highlights do not include all the information needed to use KRYSTEXXA safely and effectively. See full prescribing information for KRYSTEXXA KRYSTEXXA ® (pegloticase) Injection, for intravenous infusion Initial U.S. Approval: 2010 | 5 | |
| PEGLOTICASE | ACTIVE INGREDIENT | R581OT55EA | These highlights do not include all the information needed to use KRYSTEXXA safely and effectively. See full prescribing information for KRYSTEXXA KRYSTEXXA ® (pegloticase) Injection, for intravenous infusion Initial U.S. Approval: 2010 | 5 | |
| PEGLOTICASE | ACTIVE INGREDIENT | R581OT55EA | KRYSTEXXA (PEGLOTICASE) INJECTION, SOLUTION [CREALTA PHARMACEUTICALS LLC] | 10 | |
| PEGLOTICASE | ACTIVE MOIETY | R581OT55EA | KRYSTEXXA (PEGLOTICASE) INJECTION, SOLUTION [CREALTA PHARMACEUTICALS LLC] | 10 |